Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions 2 - ISAR-LEFT MAIN 2


Data from recent trials on left main percutaneous coronary intervention (PCI) have demonstrated promising results. The current trial sought to compare outcomes following left main PCI with two newer-generation drug eluting stents (DES): everolimus-eluting stent (EES) (Xience) versus zotarolimus-eluting stent ZES (Endeavor Resolute).